Public Health & Policy
FDA General
More in FDA General
Final rule is first update to "healthy" nutrient content claim in 30 years
Compounders only have 2 to 3 months left to copy injectable
Response rate of 70% at day 28 with remestemcel-L
In randomized study, ensartinib doubled PFS versus first-generation ALK inhibitor
The warning highlights known risk of rare but serious liver injury associated with fezolinetant
FDA approves tapinarof cream 1% for adults and kids 2 years and up
Crinecerfont reduces excessive adrenal androgen production, lowering glucocorticoid dose
PD-L1 inhibitor indicated for metastatic or locally advanced disease
Nemolizumab indicated for chronic skin disease in adults and kids ages 12 years and up
With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing
Mostly expired drugs are no longer effective against circulating SARS-CoV-2 strains
A "very complicated situation" after mRNA vaccine trial was halted, expert says
Health news and commentary gathered by 番茄社区app staff
Obeticholic acid (Ocaliva) may cause serious liver damage even in PBC patients without cirrhosis
